-
21
Drug-Induced Heart Failure (Part 2: Mechanisms of Development, Clinical Signs, Differential Diagnosis, Risk Factors, Treatment and Prevention)
Published 2020-06-01“…Безопасность и риск фармакотерапии…”
Get full text
Article -
22
Interferon Beta: Analysis of Information on Adverse Reactions and Evaluation of Possibility of Signal Identification
Published 2019-06-01“…Безопасность и риск фармакотерапии…”
Get full text
Article -
23
Automated Information Systems as a New Approach to Risk Management of Pharmacotherapy in the Treatment of Epilepsy
Published 2022-07-01“…Безопасность и риск фармакотерапии…”
Get full text
Article -
24
Risk Management in Preclinical Trials as Part of an Overall Integrated Quality Management System
Published 2020-03-01“…Безопасность и риск фармакотерапии…”
Get full text
Article -
25
Changes in Post-COVID Syndrome Manifestations and Bulbar Conjunctival Angioscopy Results in a Patient Undergoing Treatment after Mild COVID-19
Published 2022-04-01“…Безопасность и риск фармакотерапии…”
Get full text
Article -
26
Good Pharmacovigilance Practice in the United States and the European Union
Published 2022-06-01“…Безопасность и риск фармакотерапии…”
Get full text
Article -
27
Dosis facit venenum
Published 2022-06-01“…Безопасность и риск фармакотерапии…”
Get full text
Article -
28
MODERN ASPECTS OF HUMAN PAPILLOMAVIRUS VACCINATION
Published 2018-09-01“…Безопасность и риск фармакотерапии…”
Get full text
Article -
29
Complications of Pharmacotherapy with New Oral Anticoagulants Caused by Inter-Drug Interactions: Focus on Gastrointestinal Bleeding
Published 2019-06-01“…Безопасность и риск фармакотерапии…”
Get full text
Article -
30
«Propofol infusion syndrome» - case in a child of 10 years
Published 2018-02-01“…Безопасность и риск фармакотерапии…”
Get full text
Article -
31
Drug-Induced Eosinophilia
Published 2019-12-01“…Безопасность и риск фармакотерапии…”
Get full text
Article -
32
Role of Pharmacogenetic Testing in the Risk and Safety Assessment of Valproates: The Ethnic Aspect (Review)
Published 2024-07-01“…Безопасность и риск фармакотерапии…”
Get full text
Article -
33
Toxic Reactions in Probable and Confirmed Methotrexate Overdose in Rheumatology Patients: A Case Series
Published 2024-12-01“…Безопасность и риск фармакотерапии…”
Get full text
Article -
34
PCSK9 Antagonists: Clinical Efficacy and Main Trends in the Development of New Medicines
Published 2023-09-01“…Безопасность и риск фармакотерапии…”
Get full text
Article -
35
A REVIEW OF CASES OF DEVELOPMENT OF ACUTE HEPATIC INSUFFICIENCY DUE TO THE INTAKE OF BIOLOGICALLY ACTIVE ADDITIVES
Published 2018-06-01“…Безопасность и риск фармакотерапии…”
Get full text
Article -
36
Toxicity Associated with Immune Checkpoint Inhibitors: Analysis of Immune-Related Adverse Events with a Pembrolizumab Biosimilar (Pembroria)
Published 2023-06-01“…Безопасность и риск фармакотерапии…”
Get full text
Article -
37
Advanced Age as a Risk Factor of Drug-Induced Diseases
Published 2021-03-01“…Безопасность и риск фармакотерапии…”
Get full text
Article -
38
RETROSPECTIVE ANALYSIS OF REPORTED CASE OF ADVERSE DRUG REACTION - NEUROLEPTIC MALIGNANT SYNDROME ON THE USE OF HALOPERIDOL
Published 2018-02-01“…Безопасность и риск фармакотерапии…”
Get full text
Article -
39
Modern methods of identification of adverse events associated with medication errors
Published 2018-02-01“…Безопасность и риск фармакотерапии…”
Get full text
Article -
40
Combined Oral Contraceptives for Polycystic Ovary Syndrome: <i>Pro</i> and <i>Contra</i> (Review)
Published 2024-07-01“…Безопасность и риск фармакотерапии…”
Get full text
Article